About
AI technologies for drug discovery and development
Areas of Focus
Categories
AI Focused
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
443
By Phase
PHASE1: 1PHASE1/PHASE2: 1PHASE2: 1
By Status
COMPLETED: 3
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Today
Hover over trial bars to see details
Recent Trials
NCT06118385Lead Sponsor
Study Investigating the Safety, Tolerability, PK and Food Effect of BEN8744.
PHASE1Completed
76 participants
Started: Aug 30, 2023 · Completed: Mar 18, 2024
NCT04737304Lead Sponsor
A First-in-Human PoC Study With BEN2293 in Patients With Mild to Moderate Atopic Dermatitis
PHASE1/PHASE2Completed
123 participants
Started: Oct 14, 2020 · Completed: Jan 26, 2023
NCT03194217Lead Sponsor
BEN-2001 in Parkinson Disease Patients With Excessive Daytime Sleepiness
PHASE2Completed
244 participants
Started: Nov 10, 2017 · Completed: May 28, 2019
Locations (1)
Headquarters
London, UK
Map
Loading map...